PURPOSE: To evaluate the efficacy of vitrectomy with vancomycin for the treatment of experimental Bacillus cereus endophthalmitis. METHODS: Endophthalmitis was initiated in rabbits via intravitreal injection of 100 colony-forming unit B. cereus. Treatment groups included 25-gauge transconjunctival sutureless vitrectomy with intravitreal vancomycin (1 mg) or vancomycin alone. Groups were treated at 4, 5, or 6 hours after infection. At 48 hours (for 4-hour and 5-hour groups) or 36 hours (for the 6-hour group) after infection, eyes were analyzed by electroretinography, histology, and inflammatory cell counts. RESULTS: Treatment with vitrectomy/vancomycin at 4 hours resulted in significantly greater retinal function compared with that of vancomycin alone. Intraocular inflammation after treatment at 4 hours was minimal for both the treatment groups. Treatment with vitrectomy/vancomycin or vancomycin alone at 5 hours or 6 hours after infection resulted in similar levels of retinal function loss (i.e., >90%) and significant intraocular inflammation. CONCLUSION: These results demonstrate that vitrectomy may be of therapeutic benefit in the treatment of B. cereus endophthalmitis but only during the early stages of infection.
PURPOSE: To evaluate the efficacy of vitrectomy with vancomycin for the treatment of experimental Bacillus cereus endophthalmitis. METHODS:Endophthalmitis was initiated in rabbits via intravitreal injection of 100 colony-forming unit B. cereus. Treatment groups included 25-gauge transconjunctival sutureless vitrectomy with intravitreal vancomycin (1 mg) or vancomycin alone. Groups were treated at 4, 5, or 6 hours after infection. At 48 hours (for 4-hour and 5-hour groups) or 36 hours (for the 6-hour group) after infection, eyes were analyzed by electroretinography, histology, and inflammatory cell counts. RESULTS: Treatment with vitrectomy/vancomycin at 4 hours resulted in significantly greater retinal function compared with that of vancomycin alone. Intraocular inflammation after treatment at 4 hours was minimal for both the treatment groups. Treatment with vitrectomy/vancomycin or vancomycin alone at 5 hours or 6 hours after infection resulted in similar levels of retinal function loss (i.e., >90%) and significant intraocular inflammation. CONCLUSION: These results demonstrate that vitrectomy may be of therapeutic benefit in the treatment of B. cereus endophthalmitis but only during the early stages of infection.
Authors: John J Miller; Ingrid U Scott; Harry W Flynn; William E Smiddy; Timothy G Murray; Audina Berrocal; Darlene Miller Journal: Am J Ophthalmol Date: 2008-03-04 Impact factor: 5.258
Authors: Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan Journal: Prog Retin Eye Res Date: 2016-05-03 Impact factor: 21.198
Authors: Robert Rejdak; Tomasz Choragiewicz; Agnieszka Kalinowska; Michael J Koss; Piotr Ksiazek; Joanna Moneta-Wielgos; Ryszard Maciejewski; Anselm G Jünemann; Katarzyna Nowomiejska Journal: BMC Infect Dis Date: 2016-09-20 Impact factor: 3.090
Authors: Md Huzzatul Mursalin; Erin Livingston; Phillip S Coburn; Frederick C Miller; Roger Astley; Michelle C Callegan Journal: J Vis Exp Date: 2021-02-06 Impact factor: 1.355
Authors: Erin T Livingston; Md Huzzatul Mursalin; Phillip S Coburn; Roger Astley; Frederick C Miller; Omar Amayem; Didier Lereclus; Michelle C Callegan Journal: Infect Immun Date: 2021-06-07 Impact factor: 3.441
Authors: Justin van Halsema; Ruud Jansen; Adriaan Heineken; Tjaco M van Ossewaarde; Magda A Meester-Smoor; Jan C van Meurs Journal: Acta Ophthalmol Date: 2021-07-13 Impact factor: 3.988